• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】18178

【品名】4,4-piperidinediol

【CA登记号】73390-11-1

【 分 子 式 】C5H11NO2

【 分 子 量 】117.14788

【元素组成】C 51.26% H 9.46% N 11.96% O 27.31%

与该中间体有关的原料药合成路线共 6 条

合成路线1

该中间体在本合成路线中的序号:(IX)

Acid-catalyzed condensation of 4-piperidone hydrate hydrochloride (IX) with indole (IV) produced the tetrahydropyridyl indole (X). This was alkylated with 1-(2-chloroethyl)imidazolinone (XII), (prepared by chlorination of the corresponding hydroxyethyl imidazolinone (XI)) to afford the N-substituted tetrahydropyridine (XIII). The target piperidine derivative was then obtained by catalytic hydrogenation of tetrahydropyridine (XIII).

1 Perregaard, J.K. (H. Lundbeck A/S); Heterocyclic cpds.. AU 8655901; EP 0200322; ES 8707499; JP 1986236764; US 4710500 .
2 Perregaard, J.K.; Costall, B. (H. Lundbeck A/S); Piperidyl-substd. indoles. EP 0533824; JP 1993509080; US 5439922; WO 9200070 .
3 Bech Sommer, M. (H. Lundbeck A/S); Method of manufacturing sertindole. WO 9851685 .
4 Bogeso, K.P.; Hyttel, J.; Sanchez, C.; Arnt, J.; Perregaard, J.; Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles. J Med Chem 1992, 35, 6, 1092.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IV) 59582 5-chloro-1-(4-fluorophenyl)-1H-indole C14H9ClFN 详情 详情
(IX) 18178 4,4-piperidinediol 73390-11-1 C5H11NO2 详情 详情
(X) 59587 5-chloro-1-(4-fluorophenyl)-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole C19H16ClFN2 详情 详情
(XI) 59588 1-(2-hydroxyethyl)-2-imidazolidinone 3699-54-5 C5H10N2O2 详情 详情
(XII) 21329 1-(2-chloroethyl)-2-imidazolidinone 2387-20-4 C5H9ClN2O 详情 详情
(XIII) 59589 1-{2-[4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-3,6-dihydro-1(2H)-pyridinyl]ethyl}-2-imidazolidinone 106516-54-5 C24H24ClFN4O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

Treatment of a benzenic solution of 4-piperidone hydrate (I) with anhydrous AlCl3 provided 4,4-diphenylpiperidine (II). Then, conjugate addition of acrylonitrile (III) in the presence of triethylamine in ethanol gave the cyanoethylpiperidine (IV), which was reduced with borane in THF to afford the intermediate primary amine (V). Dihydropyridine (IX) was prepared by Hantzsch synthesis by condensation of 3-aminocrotonamide (VI), 4-nitrobenzaldehyde (VII) and cyanoethyl acetoacetate (VIII) in refluxing ethanol. Cyanoethyl ester was then cleaved with dilute KOH at 0 C to give acid (X), which was finally coupled with amine (V) by treatment with DEC to yield the target amide.

1 Cox, E.D.; et al.; Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate. J Med Chem 1998, 41, 14, 2643.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18178 4,4-piperidinediol 73390-11-1 C5H11NO2 详情 详情
(II) 13154 4,4-Diphenylpiperidine C17H19N 详情 详情
(III) 10847 Acrylonitrile 107-13-1 C3H3N 详情 详情
(IV) 18181 3-(4,4-diphenyl-1-piperidinyl)propanenitrile C20H22N2 详情 详情
(V) 18182 3-(4,4-diphenyl-1-piperidinyl)-1-propanamine; 3-(4,4-diphenyl-1-piperidinyl)propylamine C20H26N2 详情 详情
(VI) 18183 (E)-3-amino-2-butenamide C4H8N2O 详情 详情
(VII) 18184 4-Nitrobenzaldehyde 555-16-8 C7H5NO3 详情 详情
(VIII) 13993 2-cyanoethyl 3-oxobutanoate C7H9NO3 详情 详情
(IX) 18186 2-cyanoethyl 5-(aminocarbonyl)-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydro-3-pyridinecarboxylate C18H18N4O5 详情 详情
(X) 18187 5-(aminocarbonyl)-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydro-3-pyridinecarboxylic acid C15H15N3O5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

Synthesis of intermediate (XIV): Protection of 4-piperidone (I) with (Boc)2O in presence of DMAP and Et3N yields (II), which is converted into hydantoin (III) by means of NaCN in presence of (NH4)2CO3. Hydantoin (III) is then fully protected to provide (IV) by treatment with (Boc)2O and DMAP in THF. Alternatively (IV) can be obtained by treatment of 4-piperidone (I) with KCN in presence of (NH4)2CO3 to yield hydantoin (V), which is then protected with (Boc)2O and DMAP in DME. Hydrolysis of (IV) with NaOH affords aminoacid (VI) whose free amine is protected to provide carboxylic acid (VII). Treatment of (VII) with isobutyl chloroformate (IBCF) in DME in presence of NMM, followed by aqueous ammonia, yields amide (VIII), which is converted to (IX) by hydrogenation with H2 over Pd/C. Reductive amination of (IX) with aldehyde (X) affords amino amide (XI), which is treated with triethyl orthoformate to provide spirocycle (XII). Reduction of (XII) with NaBH4 in EtOH gives (XIII), which is alkylated with ethyl bromoacetate (A) followed by hydrolysis with NaOH to yield intermediate (XIV).

1 Wysong, C.L.; et al.; 4-Aminopiperidine-4-carboxamylic acid: A cyclic alpha,alpha-disubstituted amino acid for preparation of water-soluble highly helical peptides. J Org Chem 1996, 61, 22, 7650-51.
2 Amblard, M.; Subra, G.; Bedos, P.; et al.; A rational approach to the design and synthesis of a new bradykinin B1 receptor antagonist. J Med Chem 2000, 43, 12, 2387.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(I) 18178 4,4-piperidinediol 73390-11-1 C5H11NO2 详情 详情
(II) 18620 tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone 79099-07-3 C10H17NO3 详情 详情
(III) 41678 tert-butyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate C12H19N3O4 详情 详情
(IV) 41679 tri(tert-butyl) 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-1,3,8-tricarboxylate C22H35N3O8 详情 详情
(V) 41680 1,3,8-triazaspiro[4.5]decane-2,4-dione 13625-39-3 C7H11N3O2 详情 详情
(VI) 41681 4-amino-1-(tert-butoxycarbonyl)-4-piperidinecarboxylic acid 183673-71-4 C11H20N2O4 详情 详情
(VII) 41682 1-(tert-butoxycarbonyl)-4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4-piperidinecarboxylic acid C26H30N2O6 详情 详情
(VIII) 41683 tert-butyl 4-(aminocarbonyl)-4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-piperidinecarboxylate C26H31N3O5 详情 详情
(IX) 41684 tert-butyl 4-amino-4-(aminocarbonyl)-1-piperidinecarboxylate C11H21N3O3 详情 详情
(X) 18456 2-phenylacetaldehyde 122-78-1 C8H8O 详情 详情
(XI) 41685 tert-butyl 4-(aminocarbonyl)-4-(phenethylamino)-1-piperidinecarboxylate C19H29N3O3 详情 详情
(XII) 41686 tert-butyl 4-oxo-1-phenethyl-1,3,8-triazaspiro[4.5]dec-2-ene-8-carboxylate C20H27N3O3 详情 详情
(XIII) 41687 tert-butyl 4-oxo-1-phenethyl-1,3,8-triazaspiro[4.5]decane-8-carboxylate C20H29N3O3 详情 详情
(XIV) 41688 2-[8-(tert-butoxycarbonyl)-4-oxo-1-phenethyl-1,3,8-triazaspiro[4.5]dec-3-yl]acetic acid C22H31N3O5 详情 详情

合成路线4

该中间体在本合成路线中的序号:(IV)

The indole intermediate (V) has been obtained as follows: The reaction of 4-fluoro-2-nitrotoluene (I) with dimethylformamide dimethylacetal afforded enamine (II). Reductive cyclization of (II) by hydrogenation over Pd/C produced 6-fluoroindole (III). Subsequent condensation of indole (III) with piperidone monohydrate (IV) in the presence of KOH furnished the intermediate indolyl tetrahydropyridine (V).

1 Fairhurst, J. (Eli Lilly and Company); Substd. 4-(6-fluoro-(1H)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders. EP 0854146; WO 9831686 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48011 4-fluoro-1-methyl-2-nitrobenzene 446-10-6 C7H6FNO2 详情 详情
(II) 48012 N-[(E)-2-(4-fluoro-2-nitrophenyl)ethenyl]-N,N-dimethylamine; (E)-2-(4-fluoro-2-nitrophenyl)-N,N-dimethyl-1-ethenamine C10H11FN2O2 详情 详情
(III) 48013 6-Fluoroindole; 6-Fluoro-1H-indole 399-51-9 C8H6FN 详情 详情
(IV) 18178 4,4-piperidinediol 73390-11-1 C5H11NO2 详情 详情
(V) 18014 tert-butyl 4-[2-[2-([[(2S)-2-[[(2-bromo-4-methylphenyl)sulfonyl]amino]-3-(tert-butoxy)-3-oxopropyl]amino]carbonyl)-4-oxo-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepin-5(6H)-yl]ethyl]-1-piperidinecarboxylate C34H49BrN6O8S 详情 详情

合成路线5

该中间体在本合成路线中的序号:(IV)

Nitrosation of tetrahydrobenzothiazepine (I) with NaNO2 and HOAc, followed by LiAlH4 reduction of the resulting N-nitroso derivative (II), furnished hydrazine (III). Subsequent Fischer indole cyclization of hydrazine (III) with piperidone hydrate (IV) under acidic conditions afforded the tetracyclic system (V). The pyrrole ring double bond of (V) was then reduced employing NaBH3CN and CF3COOH to provide the racemic cis-tetracycle (VI). Resolution of (VI) was carried out by preparative chiral HPLC of the corresponding N-Boc derivative. The desired N-Boc enantiomer (VII) was then deprotected by acidic treatment to give the chiral secondary amine (VIII). This was finally alkylated with 4-chloro-4'-fluorobutyrophenone (IX) to yield the title compound.

1 Boyle, K.E.; Robichaud, A.J.; Lee, T.; et al.; Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 98.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22617 2,3,4,5-tetrahydro-1,5-benzothiazepine C9H11NS 详情 详情
(II) 48145 5-nitroso-2,3,4,5-tetrahydro-1,5-benzothiazepine C9H10N2OS 详情 详情
(III) 48146 3,4-dihydro-1,5-benzothiazepin-5(2H)-amine; 3,4-dihydro-1,5-benzothiazepin-5(2H)-ylamine C9H12N2S 详情 详情
(IV) 18178 4,4-piperidinediol 73390-11-1 C5H11NO2 详情 详情
(V) 48147 6,7,9,10,11,12-hexahydro-5H-pyrido[4,3-b][1,4]thiazepino[2,3,4-hi]indole C14H16N2S 详情 详情
(VI) 48148 6,7,8a,9,10,11,12,12a-octahydro-5H-pyrido[4,3-b][1,4]thiazepino[2,3,4-hi]indole C14H18N2S 详情 详情
(VII) 48149 tert-butyl (8aS,12aR)-6,7,9,10,12,12a-hexahydro-5H-pyrido[4,3-b][1,4]thiazepino[2,3,4-hi]indole-11(8aH)-carboxylate C19H26N2O2S 详情 详情
(VIII) 48150 (8aS,12aR)-6,7,8a,9,10,11,12,12a-octahydro-5H-pyrido[4,3-b][1,4]thiazepino[2,3,4-hi]indole C14H18N2S 详情 详情
(IX) 48151 1-(2-amino-4-fluorophenyl)-4-chloro-1-butanone C10H11ClFNO 详情 详情

合成路线6

该中间体在本合成路线中的序号:(IV)

Nitrosation of dihydrobenzoxazine (I) with NaNO2 and HOAc, followed by LiAlH4 reduction of the resulting N-nitroso derivative (II), furnished hydrazine (III). Subsequent Fischer indole cyclization of hydrazine (III) with piperidone hydrate (IV) under acidic conditions afforded the tetracyclic system (V). The pyrrole ring double bond of (V) was then reduced employing NaBH3CN and CF3COOH to provide the racemic cis-tetracycle (VI). Resolution of (VI) was carried out by preparative chiral HPLC of the corresponding N-Boc derivative. The desired N-Boc enantiomer (VII) was then deprotected by acidic treatment to give the chiral secondary amine (VIII). This was finally alkylated with 2'-amino-4-chloro-4'-fluorobutyrophenone (IX) to yield the title compound.

1 Boyle, K.E.; Robichaud, A.J.; Lee, T.; et al.; Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 98.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48152 3,4-dihydro-2H-1,4-benzoxazine C8H9NO 详情 详情
(II) 48153 4-nitroso-3,4-dihydro-2H-1,4-benzoxazine C8H8N2O2 详情 详情
(III) 48154 2,3-dihydro-4H-1,4-benzoxazin-4-amine; 2,3-dihydro-4H-1,4-benzoxazin-4-ylamine C8H10N2O 详情 详情
(IV) 18178 4,4-piperidinediol 73390-11-1 C5H11NO2 详情 详情
(V) 48155 1,2,7,8,9,10-hexahydro[1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole C13H14N2O 详情 详情
(VI) 48156 1,2,6b,7,8,9,10,10a-octahydro[1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole C13H16N2O 详情 详情
(VII) 48157 tert-butyl (6bR,10aS)-1,2,6b,9,10,10a-hexahydro[1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole-8(7H)-carboxylate C18H24N2O3 详情 详情
(VIII) 48158 (6bR,10aS)-1,2,6b,7,8,9,10,10a-octahydro[1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole C13H16N2O 详情 详情
(IX) 48151 1-(2-amino-4-fluorophenyl)-4-chloro-1-butanone C10H11ClFNO 详情 详情
Extended Information